Comparative phagocytic activities of human THP-1 macrophage and breast cancer cell line (MCF-7) against monosodium urate monohydrate (MSU) crystals using direct visualization and indirect flow cytometry side-scatter. Using flow cytometry, MSU phagocytosis was determined by the change in side scatter distribution of cells (THP-1 or MCF-7) following a 4-hour incubation. Two regions of interest were identified; P1 representing the cell population in the absence of MSU exposure and P2 representing the cell population with increased side scatter due to MSU phagocytosis. The percentage of positive cells was calculated as the number of cells in P2 region divided by the number of cells in P1+P2 regions. *p<0.001; n.s.: nonsignificant; Scale bar = 25µm. A) Representative images showing crystals in MSUtreated THP-1 macrophages (white arrows) while no crystals were detected in MSUtreated MCF-7 cells. B) Representative flow cytometry plots of control THP-1 cells, MSU-treated THP-1 cells, control MCF-7 cells and MSU-treated MCF-7 cells showing localization of THP-1 cells in P2 region due to MSU phagocytosis. C) MSU phagocytosis was observed in THP-1 macrophages using side-scatter analysis but not in MCF-7 cells. A B Control (THP-1) MSU (THP-1) Control (MCF-7) MSU (MCF-7) Control (THP-1) MSU (THP-1) Control (MCF-7) C MSU (MCF-7)
Supplementary Figure 2
Representative flow cytometry plots depicting the impact of antibody-mediated CD44 receptor shedding on monosodium urate monohydrate (MSU) crystals phagocytosis by differentiated human THP-1 macrophages. MSU phagocytosis was determined by the change in side scatter distribution of macrophages following a 4hour incubation. Two regions of interest were identified; P1 representing the macrophage population in the absence of MSU exposure and P2 representing the macrophage population with increased side scatter due to MSU phagocytosis in the presence or absence of anti-CD44 or isotype control (IC) antibodies (2µg/mL for both antibodies). A) Control; B) MSU; C) MSU+Anti-CD44; D) MSU+IC; E) Anti-CD44 and F) IC.
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